CRISPR Therapeutics AG (CRSP)
53.90
+0.17
(+0.32%)
USD |
NASDAQ |
Apr 26, 16:00
53.56
-0.34
(-0.63%)
After-Hours: 16:47
CRISPR Therapeutics Stock Buybacks (Quarterly): -32.72M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -32.72M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.97M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 1.325M |
| March 31, 2021 | -214.59M |
| December 31, 2020 | -400.06M |
| September 30, 2020 | -499.20M |
| June 30, 2020 | -83.02M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | -293.80M |
| September 30, 2019 | -68.92M |
| June 30, 2019 | -28.40M |
| March 31, 2019 | -23.89M |
| December 31, 2018 | 1.966M |
| September 30, 2018 | -186.42M |
| June 30, 2018 | 0.05M |
| March 31, 2018 | -122.60M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -89.04M |
| September 30, 2016 | -0.016M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-499.20M
Minimum
Sep 2020
1.325M
Maximum
Jun 2021
-108.02M
Average
-28.40M
Median
Jun 2019
Stock Buybacks (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 152.70M |
| Intellia Therapeutics Inc | -103.61M |
| Novartis AG | 1.099B |
| Verve Therapeutics Inc | -176.76M |
| AC Immune SA | -45.80M |